Greenwich LifeSciences, Inc.
GLSI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001799788
In the last 90 days, Greenwich LifeSciences, Inc. insiders filed 3 open-market purchases and 0 sales; 57 institutions reported holding it in 13F filings for Q2 2026, worth $39.6M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Greenwich LifeSciences, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 22 | 28 | +6 |
| Shares | 671.4K | 827.5K | +156.1K (+23.3%) |
| Value | $10.2M | $11.4M | +$1.21M (+11.9%) |
New holders (6)
Institutions that held Greenwich LifeSciences, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 37,100 | $511.6K | 0.00% |
| HRT Financial LP | 18,606 | $256.0K | 0.00% |
| Jane Street Group, LLC | 18,510 | $255.3K | 0.00% |
| Citigroup Inc | 12,498 | $172.3K | 0.00% |
| Citadel Advisors LLC | 10,354 | $142.8K | 0.00% |
| AdvisorNet Financial, Inc | 50 | $690 | 0.00% |
Sold out (0)
Institutions that held Greenwich LifeSciences, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
None.